Background: Data related to HIV-positive patients with dental implants is short-termed and limited. Recent data showed that both HIV and antiretroviral therapy (ART) could lead to low bone mineral density (BMD). The aim of this study was to determine the success rate of dental implants in HIV-positive patients.
Materials and methods: Dental files of 67 HIV-positive patients were selected and reviewed retrospectively, and 18 subjects agreed to return for examination. All implants were evaluated using periapical radiographs that were calibrated to measure bone loss. Crestal bone loss, mobility, and lack of infection were the parameters used to determine implant success.
Results: All dental implants evaluated lacked mobility and infection. Bone loss averaged 0.5 mm in 3.6 years. Subjects were consistent with maintenance and oral hygiene.
Conclusions: Within the limitations of this study, the results suggest that the placement of dental implants on HIV-positive patients is safe and effective.
Keywords: Antiretroviral therapy; Bone loss; Dental implant; HIV-positive patients.
Conflict of interest statement
Nadine Cordero Rubinstein, Zhimon Jacobson, Serge Dibart, and Gail McCausland declare that they have no competing interests.
- Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–1174. doi: 10.1126/science.1193748. - DOI - PMC - PubMed
- Facts F. HIV in the United States: at a glance. 2013.